Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Hanseul Kim Image

      Hanseul Kim, Ph.D.

      Department of Epidemiology, Division of Cancer Prevention and Population Sciences

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Epidemiology, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Affiliate, Institute for Data Science in Oncology (IDSO), The University of Texas MD Anderson Cancer Center, Houston, Texas

      Regular Member, UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2022Harvard T. H. Chan School of Public Health, Boston, MA, US, Epidemiology, Doctor of Philosophy in Population Health Sciences
      2017Harvard T. H. Chan School of Public Health, Boston, MA, US, Biostatistics, Master of Science
      2014Rice University, Houston, TX, US, Statistics and Psychology, Bachelor of Arts

      Postgraduate Training

      2021-2025Postdoctoral Research Fellow, Microbiome and Translational Epidemiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA

      Honors & Awards

      2024 - 2025NIH National Research Service Award T32 CA 009001 Postdoctoral Researcher
      2024Fellow Abstract Award, American Gastroenterological Association
      2023Program in Quantitative Genomics Postdoc Travel Award, Harvard T.H. Chan
      2015 - 2016Harvard Chan Central Grant, Harvard T.H. Chan
      2014Magna Cum Laude, Rice University
      2013 - 2014Louis J. Walsh Scholarship in Engineering, Rice University
      2011 - 2014President’s Honor Roll, Rice University

      Selected Presentations & Talks

      Local Presentations

      1. 2026. Leveraging microbiome multi-omics for cancer prevention. Invited. Cancer Prevention and Control Grand Rounds. Houston, Texas, US.
      2. 2025. Linking dietary and microbial multi-omics data: insights into cancer and metabolic disease. Invited. Epidemiology Department Seminar. Houston, Texas, US.

      Regional Presentations

      1. 2025. Bridging nutrition and microbiome-focused multi-omics to advance cancer research. Invited. Quantitative Sciences Division Seminar. Baltimore, Maryland, US.
      2. 2025. Integrating dietary and microbial multi-omics data in chronic disease epidemiology. Invited. Chronic Disease Epidemiology Seminar. New Haven, Connecticut, US.
      3. 2024. An integrated gut multi-omic transkingdom interrogation of metabolic dysfunction-associated steatotic liver disease (MASLD). Invited. Multiple Omics Seminar. Boston, Massachusetts, US.
      4. 2023. Alterations in gut microbial composition and metabolites in non-alcoholic fatty liver disease. Invited. Microbiome Epidemiology Working Group. Boston, Massachusetts, US.
      5. 2021. Vitamin D, calcium, and early-onset colorectal neoplasia. Invited. Research Seminar. Boston, Massachusetts, US.
      6. 2019. Vitamin D and cancer mortality: state of the evidence and next steps after the VITAL trial. Invited. Hot Topics in Cancer Epidemiology Series. Boston, Massachusetts, US.

      National Presentations

      1. 2024. Altered microbial transcription in long-term proton pump inhibitor use. Invited. Digestive Disease Week (DDW). Washington, D.C, District of Columbia, US.
      2. 2024. Concurrent and habitual diet differentially associate with microbial multi-omic profiles in inflammatory bowel disease. Poster. Digestive Disease Week (DDW). Washington, D.C, District of Columbia, US.
      3. 2023. Population-level impact of a metabolically- and microbially-informed diet on weight change and obesity-related complications. Invited. Digestive Disease Week (DDW). Chicago, Illinois, US.
      4. 2023. Alterations in gut microbial composition, metabolites, and transcriptional activity among participants with non-alcoholic fatty liver disease. Invited. Digestive Disease Week (DDW),. Chicago, Illinois, US.
      5. 2023. Prediagnostic vitamin D status and colorectal cancer survival by vitamin D-binding protein isoforms in the US cohorts. Poster. Orlando, Florida, US.
      6. 2022. Changes in taxonomic and metabolic composition among patients with non-alcoholic fatty liver disease. Poster. Keystone Symposia Conference: Interconnection between the Gut, Brain, and Microbiome for Metabolic Disease, US.
      7. 2021. Vitamin D and early-onset colon cancer. Invited. 2nd Annual Colorectal Cancer Congress. Washington, D.C, District of Columbia, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2027
      Title:Diet-microbiome integration in Mexican American Cohort
      Funding Source:Houston Nutrition and Obesity Research Center (HNORC)
      Role:PI
      Date: 2026 - 2031
      Title:Multi-omic approaches to exploring the gut microbiome and metabolic dysfunction-associated steatotic liver disease (MASLD)
      Funding Source:NIH/NIDDK
      Role:PI
      ID:DK141967

      Selected Publications

      Peer-Reviewed Articles

      1. Nogal A, Wang K, Thompson KN, Kim H, Bhosle A, Piccinno G, Maharjan S, Upreti C, Nguyen LH, Segata N, Rimm EB, Garrett WS, Chan AT, Huttenhower C, Song M. Long-lasting gut microbiome and fecal metabolome alterations after colorectal adenoma removal and their relationship to colorectal cancer. Cell Host Microbe 34(6):1135-1150.e6, 2026. e-Pub 2026. PMID: 42202778.
      2. Tangpradubkiat P, Roberts AL, Cardona B, Kim H, Ogino S, Giovannucci EL, Song M, Chan AT. Association between depression and risk of colorectal cancer and polyps: A prospective cohort study from Nurses' Health Study II. Cancer Epidemiol Biomarkers Prev, 2026. e-Pub 2026. PMID: 42132476.
      3. Zhou X, Zhou D, Pu Y, Kim H, Sun Z, Qi W, Jin J, Zhang W, Xia M, Wang C, Hong S, Nguyen LH, Jiao N, Zheng Y, Liu T. Multi-kingdom profiling reveals altered gut phage-bacteria-metabolite interactions in MASLD. Nat Commun 17(1), 2026. e-Pub 2026. PMID: 42000726.
      4. Dinesh, D, Morgan, XC, Kim, H, Scott, TM, Garelnabi, M, Lee, JS, Mangano, KM, Nguyen, LH, Huttenhower, C, Tucker, KL, Palacios, N. Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study. Pharmacology Research and Perspectives 14(1), 2026. e-Pub 2026. PMID: 41437205.
      5. Wang, C, Du, M, Kim, H, Nguyen, LH, Wang, QL, Drew, DA, Leeming, ER, Khandpur, N, Sun, Q, Zong, X, Gweon, TG, Ogino, S, Ng, K, Berry, SE, Giovannucci, E, Song, M, Cao, Y, Chan, AT. Ultraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among Women. JAMA Oncology 12(1):49-57, 2026. e-Pub 2026. PMID: 41231486.
      6. Chen, AY, Kim, H, Nzabarushimana, E, Shen, J, Williams, K, Gurung, J, McGoldrick, J, Burke, KE, Yarze, JC, Nguyen, LH, Staller, K, Chung, D, Xavier, RJ, Khalili, H. Association of distinct microbial and metabolic signatures with microscopic colitis. Nature communications 16(1), 2025. e-Pub 2025. PMID: 40410138.
      7. Kim H, Nelson P, Nzabarushimana E, Shen J, Jensen J, Bhosle A, Li C, Lee N, Everett C, Berdy B, Frongillo G, Livny J, Hu FB, Simon TG, McIver L, Franzosa EA, Chan AT, Hayete B, Thompson KN, Huttenhower C, Nguyen LH. Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease. Nat Metab 7(7):1476-1492, 2025. e-Pub 2025. PMID: 40604156.
      8. Piperni E, Nguyen LH, Manghi P, Kim H, Pasolli E, Andreu-Sanchez S, Arre A, Bermingham KM, Blanco-Miguez A, Manara S, Valles-Colomer M, Bakker E, Busonero F, Davies R, Fiorillo E, Giordano F, Hadjigeorgiou G, Leeming ER, Lobina M, Masala M, Maschio A, McIver LJ, Pala M, Pitzalis M, Wolf J, Fu J, Zhernakova A, Caccio SM, Cucca F, Berry SE, Ercolini D, Chan AT, Huttenhower C, Spector TD, Segata N, Asnicar F. Intestinal Blastocystis is linked to healthier diets and more favorable cardiometabolic outcomes in 56,989 individuals from 32 countries. Cell 187(17):4554-4570.e18, 2024. e-Pub 2024. PMID: 38981480.
      9. Kim H, Nzabarushimana E, Huttenhower C, Chan AT, Nguyen LH. Altered Microbial Transcription in Long-term Proton Pump Inhibitor Use: Findings From a United States Cohort Study. Gastroenterology 167(2):405-408.e3, 2024. e-Pub 2024. PMID: 38521094.
      10. Yuan C, Wang QL, Kim H, Babic A, Zhang J, Wolpin BM, Wu K, Song M, Ogino S, Meyerhardt JA, Chan AT, Cao Y, Giovannucci EL, Ng K. Being Breastfed in Infancy and Risk of Colorectal Cancer and Precursor Lesions. Clin Gastroenterol Hepatol 22(7):1508-1517.e11, 2024. e-Pub 2024. PMID: 37683882.
      11. Kim J, Zhang Y, Kim H, Zhang Y, Zhang X, Giovannucci E. A Comparative Study of Healthy Dietary Patterns for Incident and Fatal Digestive System Cancer. Am J Gastroenterol 118(11):2061-2070, 2023. e-Pub 2023. PMID: 37543749.
      12. Wu Y, Kim H, Wang K, Song M, Wang M, Tamimi R, Eliassen H, Smith-Warner SA, Willett WC, Giovannucci EL. Influence of analytic methods, data sources, and repeated measurements on the population attributable fraction of lifestyle risk factors. Eur J Epidemiol 38:717-728, 2023. e-Pub 2023. PMID: 37280503.
      13. Kim J, Khil J, Kim H, Keum N, Zhang X, Giovannucci E. Plant-based dietary patterns and the risk of digestive system cancers in 3 large prospective cohort studies. Eur J Epidemiol 38:617-627, 2023. e-Pub 2023. PMID: 37101016.
      14. Kim H, Hur J, Wu K, Song M, Wang M, Smith-Warner SA, Zhang X, Giovannucci EL. Total calcium, dairy foods and risk of colorectal cancer: a prospective cohort study of younger US women. Int J Epidemiol 52(1):87-95, 2023. e-Pub 2023. PMID: 36315018.
      15. Kim H, Yuan C, Nguyen LH, Ng K, Giovannucci EL. Prediagnostic Vitamin D Status and Colorectal Cancer Survival by Vitamin D Binding Protein Isoforms in US Cohorts. J Clin Endocrinol Metab 108(6):e223-e229, 2022. e-Pub 2022. PMID: 36550068.
      16. Goon S, Kim H, Giovannucci EL. Population attributable risk for colorectal and breast cancer in England, Wales, Scotland, Northern Ireland, and the United Kingdom. AMRC Open Res 3:11, 2022. e-Pub 2022. PMID: 38708073.
      17. Kim H, Wang K, Song M, Giovannucci EL. A comparison of methods in estimating population attributable risk for colorectal cancer in the United States. Int J Cancer 148(12):2947-2953, 2021. e-Pub 2021. PMID: 33527363.
      18. Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M, Smith-Warner SA, Fuchs C, Ogino S, Wu K, Chan AT, Cao Y, Ng K, Giovannucci EL. Total vitamin D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161(4):1208-1217. e9, 2021. e-Pub 2021.
      19. Kim H, Chandler P, Ng K, Manson JE, Giovannucci E. Obesity and efficacy of vitamin D(3) supplementation in healthy black adults. Cancer Causes Control 31(4):303-307, 2020. e-Pub 2020. PMID: 32052217.
      20. Kim H, Keum N, Giovannucci EL, Fuchs CS, Bao Y. Garlic intake and gastric cancer risk: Results from two large prospective US cohort studies. Int J Cancer 143(5):1047-1053, 2018. e-Pub 2018. PMID: 29569711.
      21. Kim H, Giovannucci EL. Sex differences in the association of obesity and colorectal cancer risk. Cancer Causes Control 28(1):1-4, 2017. e-Pub 2017. PMID: 27878394.

      Other Articles

      1. Collese TS, Norde MM, Nascimento-Ferreira MV, Kim H, Marchioni DM, Carvalho HB, Giovannucci E Which blood cutoff value should be used for vitamin A deficiency in children aged 3-10 years? A systematic review. Nutr Rev 79(7):777-787, 2021. PMID: 33382883.
      2. Oh H, Kim H, Lee DH, Lee A, Giovannucci EL, Kang SS, Keum N Different dietary fibre sources and risks of colorectal cancer and adenoma: a dose-response meta-analysis of prospective studies. Br J Nutr 122(6):605-615, 2019. PMID: 31495339.
      3. Keum N, Kim H, Giovannucci EL Calcium as a chemopreventive agent against colorectal neoplasm: does obesity play a role?. Cancer Causes Control 28(8):853-856, 2017. PMID: 28677025.

      Abstracts

      1. Thompson KN, Ma S, Bhosle A, Nickols WA, Ghazi A, Zhang Y, Nzabarushimana E, Kim H, Xavier R, Chan AT, Franzosa EA, Huttenhower C, Nguyen LH. 496 Harmonized metagenomic signatures of gut microbial communities reveal strain-specific links to inflammatory bowel disease. Gastroenterology 166(5):S-115-S-116, 2025. e-Pub 2025.
      2. Kim H, Kim H, Shen J, Nzabarushimana E, Zhao L, Zhang X, Simon TG, Ma W, Chan AT, Nguyen LH. Su1715 Modifiable lifestyle factors and risk of hepatocellular carcinoma and liver-related mortality. Gastroenterology. Gastroenterology 169(1):S-1765-S-1766, 2025. e-Pub 2025.
      3. Gweon T, Kim H, Ha J, Du M, Song M, Chan AT. 908 Association between sugar-sweetened and artificially sweetened beverage intake and gastric cancer incidence. Gastroenterology 169(1):S-217, 2025. e-Pub 2025.
      4. Wang C, Du M, Kim H, Nguyen LH, Khandpur N, Sun Q, Zong X, Giovannucci E, Drew DA, Song M, Cao Y, Chan AT. 178 Ultra-processed food consumption and risk of early-onset colorectal cancer precursors among women: A prospective US cohort study. Gastroenterology 169(1):S-46, 2025. e-Pub 2025.
      5. Nzabarushimana E, Münch PC, Shen J, Kim H, Sikavi D, Hsu T, McHardy AC, Franzosa EA, Huttenhower C, Nguyen LH. 1046 Pulsed antibiotic therapy and lateral gene transfer events. Gastroenterology 169(1):S-255-S-256, 2025. e-Pub 2025.
      6. Shirai N, Okeagu P, Nzabarushimana E, Shen J, Yan Y, Drew DA, Kim H, Chung D, Thompson KN, Stadler Z, Huttenhower C, Chan AT, Nguyen LH. Mo2007 Transkingdom gut dysbiosis in lynch syndrome. Gastroenterology 169(1):S-1265-S-1266, 2025. e-Pub 2025.
      7. Kim H, Leeming E, Merino J, Kim D, Drew DA, Asnicar F, Linenberg I, Bermingham K, Francis L, Wolf J, Spector T, Segata N, Huttenhower C, Berry S, Nguyen LH, Chan AT. 1244 Population-level impact of a metabolically- and microbially-informed diet on weight change and obesity-related complications. Gastroenterology 164(6):S-257, 2025. e-Pub 2025.
      8. Nogal A, Thompson KN, Nguyen LH, Kim H, Wang K, Lu Y, Du M, Piccinno G, Segata N, Rimm EB, Garrett W, Chan AT, Huttenhower C, Song M. Mo2018 Mapping the gut microbiome and fecal metabolome signature along the colorectal adenoma-carcinoma continuum. Gastroenterology 169(1):S-1269-S-1270, 2025. e-Pub 2025.
      9. Shen J, Nzabarushimana E, Kim H, Jensen J, Nickols WA, Sikavi D, Sang E, Chung L, Okeagu P, Shirai N, Franzosa E, Huttenhower C, Chan AT, Thompson KN, Nguyen LH. 1326 Perturbed gut viral ecology in inflammatory bowel disease: A multi-cohort study. Gastroenterology 169(1):S-332-S-333, 2025. e-Pub 2025.
      10. Chen AS, Kim H, Nzabarushimana E, Shen J, Williams KM, Gurung J, McGoldrick J, Burke KE, Yarze JC, Nguyen LH, Staller K, Chung D, Xavier R, Khalili H. 629 Composition and Function of the Gut Microbiome in Microscopic Colitis. Gastroenterology 169(1):S-152, 2025. e-Pub 2025. PMID: 39574841.
      11. Kim H, Nzabarushimana E, Huttenhower C, Chan AT, Nguyen LH. 871 Metatranscriptomic activity of oral-typical microbes in proton pump inhibitor usage. Gastroenterology 166(5):S-201-S-202, 2024. e-Pub 2024.
      12. Nzabarushimana E, Kim H, Jensen J, Shen J, Nelson P, Thompson KN, Chan AT, Hayete B, Huttenhower C, Nguyen LH. 4 Altered gut viral ecology in metabolic dysfunction-associated steatotic liver disease. Gastroenterology 166(5):S-1539-S-1540, 2024. e-Pub 2024.
      13. Kim DY, Sikavi D, Kim H, Wang Y, Mehta RS, Nzabarushimana E, Khalili H, Ananthakrishnan A, Huttenhower C, Chan AT, Nguyen LH. 635 The sulfur microbial diet and risk of inflammatory bowel disease. Gastroenterology 164(6):S-126, 2023. e-Pub 2023.
      14. Kim H, Nelson P, Thompson KN, Nguyen LH, Hayete B, Huttenhower C. 446 Alterations in gut microbial composition, metabolites, and transcriptional activity among participants with nonalcoholic fatty liver disease. Gastroenterology 164(6):S-1250, 2023. e-Pub 2023.
      15. Nzabarushimana E, VanEvery HL, Kim H, Mehta R, Zhang Y, Ma W, Thompson KN, Kim DY, Cao Y, Khalili H, Ananthakrishnan A, Franzosa EA, Chan AT, Huttenhower C, Nguyen LH. 276 Interactions between host dietary intake and gut microbial transcription in inflammatory bowel disease. Gastroenterology 164(6):S-50, 2023. e-Pub 2023.

      Book Chapters

      1. Kim H, Shui I, Giovannucci E. Vitamin D status and cancer incidence, mortality, and prognosis. In: Feldman and Pike's Vitamin D. 5. Academic Press, 719-739, 2024.
      2. Kim, H, Shui, IM, Giovannucci, EL. Vitamin D status and cancer incidence, mortality, and prognosis, 719-739, 2023.
      3. Kim H, Giovannucci E. Vitamin D Status and Cancer Incidence, Survival, and Mortality. In: Sunlight, Vitamin D and Skin Cancer, 39-52, 2020.

      Letters to the Editor

      1. Kim H, Song M, Giovannucci EL. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study. Cancer 124: 212-213, 2018.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 31, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top